The Bull Case For AbbVie (ABBV) Could Change Following EU Approval Of Rinvoq For Vitiligo Simply Wall St 12:12 Wed, 29 Jul
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata AbbVie (Press Release) 08:00 Wed, 29 Jul
AbbVie vs. Abbott Laboratories: Which healthcare stock is a better buy in 2026? The Motley Fool 4h Abbott Labs Pharma
AbbVie’s Cork employees transform local school as part of company’s 11th... The Avondhu 3d Biotech Biotechnology Pharma
AbbVie’s Rinvoq approved by European Commission for non-segmental vitiligo PMLiVE 8d Biotech Pharma Rinvoq All sources
LifeMine gets $263m for transplant drug, and other financing... pharmaphorum 15h Biotechnology Pharma
STAT Plus: Study reveals new role for tau, a top target for Alzheimer’s drug development STAT 1d Biotechnology Pharma Science
Artificial intelligence has created new viable viruses that do not exist in nature for the first time UNN.ua 1d Biotechnology AI Pharma
